Gastrointestinal Cancer News

The FDA granted orphan drug designation to nadunolimab for the treatment of pancreatic cancer.

To advance health equity, it is time to normalize the collection of sexual orientation and gender identity (SOGI) data in clinical practice and in health services research.

Standard cancer care may fail to adequately address the needs of LGBTQ+ individuals, who face substantial disparities in access to screening, treatment and outcomes.

The FDA granted fast track designation to CT-0508 for treatment of patients with solid tumors that overexpress human epidermal growth factor receptor 2.

More than a third of patients with solid tumors showed evidence of antitumor response after treatment with ADP-A2M4CD8, according to data presented at the virtual ESMO Congress.

Fully automated magnetically controlled capsule endoscopy performed similarly to conventional transoral gastroscopy and may be an effective method for gastrointestinal tract examination, according to research.

Women who miss cancer screenings face higher morbidity and mortality risks, and race may indicate who is more likely to get those screenings, according to a study presented at the North American Menopause Society Annual Meeting.

People with MS had lower overall and cancer-specific survival soon after colorectal cancer diagnosis compared with those without MS, according to results of a retrospective matched cohort study published in Neurology.

Hispanic adults had lower rates of overall cancer incidence between 2014 and 2018, but higher rates of liver and stomach cancers compared with whites, according to study results published in CA: A Cancer Journal for Clinicians.

Patients who underwent complete omentectomy for gastric cancer had decreased overall survival rates compared with patients who underwent non-complete omentectomy, according to research published in BMC Gastroenterology.